Logo image of ATRC

ATRICURE INC (ATRC) Stock Fundamental Analysis

NASDAQ:ATRC - Nasdaq - US04963C2098 - Common Stock - Currency: USD

35.84  +0.22 (+0.62%)

After market: 35.84 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ATRC. ATRC was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ATRC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ATRC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ATRC has reported negative net income.
In the past year ATRC had a positive cash flow from operations.
In the past 5 years ATRC reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ATRC reported negative operating cash flow in multiple years.
ATRC Yearly Net Income VS EBIT VS OCF VS FCFATRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of ATRC (-5.97%) is better than 64.71% of its industry peers.
Looking at the Return On Equity, with a value of -7.83%, ATRC is in the better half of the industry, outperforming 66.31% of the companies in the same industry.
Industry RankSector Rank
ROA -5.97%
ROE -7.83%
ROIC N/A
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ATRC Yearly ROA, ROE, ROICATRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

The Gross Margin of ATRC (74.71%) is better than 87.70% of its industry peers.
ATRC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ATRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
ATRC Yearly Profit, Operating, Gross MarginsATRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATRC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ATRC has been increased compared to 5 years ago.
Compared to 1 year ago, ATRC has a worse debt to assets ratio.
ATRC Yearly Shares OutstandingATRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ATRC Yearly Total Debt VS Total AssetsATRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ATRC has an Altman-Z score of 7.41. This indicates that ATRC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.41, ATRC belongs to the best of the industry, outperforming 86.63% of the companies in the same industry.
The Debt to FCF ratio of ATRC is 8.42, which is on the high side as it means it would take ATRC, 8.42 years of fcf income to pay off all of its debts.
ATRC has a Debt to FCF ratio of 8.42. This is in the better half of the industry: ATRC outperforms 75.40% of its industry peers.
ATRC has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
ATRC has a Debt to Equity ratio (0.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 8.42
Altman-Z 7.41
ROIC/WACCN/A
WACC8.89%
ATRC Yearly LT Debt VS Equity VS FCFATRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

ATRC has a Current Ratio of 3.94. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ATRC (3.94) is better than 66.84% of its industry peers.
A Quick Ratio of 2.83 indicates that ATRC has no problem at all paying its short term obligations.
ATRC has a better Quick ratio (2.83) than 65.78% of its industry peers.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 2.83
ATRC Yearly Current Assets VS Current LiabilitesATRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.33% over the past year.
The Revenue has grown by 16.28% in the past year. This is quite good.
ATRC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.05% yearly.
EPS 1Y (TTM)52.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%17.09%

3.2 Future

The Earnings Per Share is expected to grow by 23.01% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.30% on average over the next years. This is quite good.
EPS Next Y22.71%
EPS Next 2Y21.79%
EPS Next 3Y24.41%
EPS Next 5Y23.01%
Revenue Next Year12.84%
Revenue Next 2Y12.73%
Revenue Next 3Y12.85%
Revenue Next 5Y13.3%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ATRC Yearly Revenue VS EstimatesATRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ATRC Yearly EPS VS EstimatesATRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATRC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATRC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATRC Price Earnings VS Forward Price EarningsATRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ATRC is valued a bit cheaper than 67.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 214.08
EV/EBITDA N/A
ATRC Per share dataATRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

ATRC's earnings are expected to grow with 24.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.79%
EPS Next 3Y24.41%

More info and screens

0

5. Dividend

5.1 Amount

ATRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATRICURE INC

NASDAQ:ATRC (8/19/2025, 8:00:01 PM)

After market: 35.84 0 (0%)

35.84

+0.22 (+0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners104.63%
Inst Owner Change-3.14%
Ins Owners3.46%
Ins Owner Change7.8%
Market Cap1.77B
Analysts85.33
Price Target52.02 (45.15%)
Short Float %4.66%
Short Ratio4.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.19%
Min EPS beat(2)40.06%
Max EPS beat(2)88.31%
EPS beat(4)4
Avg EPS beat(4)52.14%
Min EPS beat(4)14.39%
Max EPS beat(4)88.31%
EPS beat(8)7
Avg EPS beat(8)29.57%
EPS beat(12)10
Avg EPS beat(12)31.55%
EPS beat(16)11
Avg EPS beat(16)69.13%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)2.54%
Revenue beat(4)2
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-1.4%
Max Revenue beat(4)2.54%
Revenue beat(8)3
Avg Revenue beat(8)0.09%
Revenue beat(12)6
Avg Revenue beat(12)0.47%
Revenue beat(16)9
Avg Revenue beat(16)0.75%
PT rev (1m)1.24%
PT rev (3m)1.24%
EPS NQ rev (1m)19.88%
EPS NQ rev (3m)28.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.35%
Revenue NQ rev (3m)1.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.55
P/FCF 214.08
P/OCF 48.7
P/B 3.82
P/tB 10
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)0.17
FCFY0.47%
OCF(TTM)0.74
OCFY2.05%
SpS10.1
BVpS9.38
TBVpS3.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.97%
ROE -7.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.71%
FCFM 1.66%
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 8.42
Debt/EBITDA N/A
Cap/Depr 140.66%
Cap/Sales 5.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.94
Quick Ratio 2.83
Altman-Z 7.41
F-Score4
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)184.3%
Cap/Depr(5y)140.27%
Cap/Sales(3y)6.89%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
EPS Next Y22.71%
EPS Next 2Y21.79%
EPS Next 3Y24.41%
EPS Next 5Y23.01%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%17.09%
Revenue Next Year12.84%
Revenue Next 2Y12.73%
Revenue Next 3Y12.85%
Revenue Next 5Y13.3%
EBIT growth 1Y2.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.67%
EBIT Next 3Y62.94%
EBIT Next 5Y43.2%
FCF growth 1Y117.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1396.48%
OCF growth 3YN/A
OCF growth 5YN/A